Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

Holders of 5% or more of BIOL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biolase, Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Biolase, Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Biolase, Inc, newest first.

Schedule 13D and 13G filings on BIOL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 9, 2023Perkins Capital Management Inc13GOld format–New–SEC
Jan 20, 2023Lytton Laurence W13GOld format–New–SEC
Jan 13, 2023Lind Global Fund II LP13GOld format–New–SEC
Feb 15, 2022Armistice Capital, LLC13G/AOld format–––SEC
Feb 11, 2022Intracoastal Capital, LLC13G/AOld format–––SEC
Jul 2, 2021Schuler Jack W13D/AOld format–––SEC
Feb 16, 2021Armistice Capital, LLC13G/AOld format–––SEC
Feb 16, 2021Archon Capital Management LLC13G/AOld format–––SEC
Feb 4, 2021Feinberg Larry N13D/AOld format–––SEC
Jan 29, 2021Intracoastal Capital, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Biolase, Inc shares.

No Form 144 notices for Biolase, Inc are on file.